Shanxi Antai Enyi Biotechnology Development Co., Ltd. announced that it has received CNY 5 million in an equity round of funding on January 12, 2024. The transaction will include participation from returning investor, Shanxi Antai Group Co.,Ltd. After the capital increase is completed, the registered capital of company will be changed from CNY 15 million to CNY 20 million. And investor stake will increases from 70% to 77.5% in the company.

The transaction within the approval authority of the chairman of the board and does not need to be submitted to the Shanxi Antai Group Co.,Ltd. board of directors and shareholders' meeting for review.